Samsung Biologics announced it has attained ISO 22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class business continuity management system (BCMS).
ISO 22301 is the international standard for business continuity management published by the International Organization for Standardization. Managing to ISO 22301 levels is itself a rigorous endeavor and achieving certification is an indication of an organization’s robust and sustained ability to prevent, prepare for, respond to, and recover from unexpected and disruptive incidents.
In 2018, Samsung Biologics was the first to achieve ISO 22301 certification in the biologics CMO industries for Plant 1, Plant 2, and support functions as validated by the British Standard Institution (BSI) certification body...
Full text at GMPnews.Net